Abstract
Relapses in vivax malaria have posed great challenges for malaria control, and they also account for a great proportion of reported cases. Knowing the real effectiveness of a 7-day primaquine (PQ) scheme is crucial in order to evaluate not only the cost-effectiveness of implementing new anti-hypnozoite drugs, but also how health education strategies can guarantee better compliance and be reinforced. This study aimed to evaluate the effect of daily treatment with chloroquine and PQ supervised by health workers versus prescription without supervision. The outcome was the passive detection of new positive thick blood smears up to 180 days, based on the official data records from the National Malaria Control Programme. The recurrences seen in the real life were, therefore, used as a surrogate for true relapses. Patients under supervised treatment had a lower risk of recurrence up to day 180 when compared to the unsupervised treatment (17.9% vs. 36.1%; p = 0.027). The lack of supervision in the non-supervised group (which followed standard of care in the real life) enabled proper comparison, as consent itself would have lead to greater compliance in this group. Future studies should scale such an analysis to different settings in th...Continue Reading
References
May 19, 2000·Antimicrobial Agents and Chemotherapy·S PukrittayakameeN J White
Jun 7, 2003·Tropical Medicine & International Health : TM & IH·Elisabeth C Duarte, Theresa W Gyorkos
Feb 1, 2005·Tropical Medicine & International Health : TM & IH·Shunmay Yeung, Nicholas J White
Apr 20, 2011·Malaria Journal·Tzvi PollockAna Rodriguez
Dec 15, 2011·Malaria Journal·Elza A PereiraCor J F Fontes
Sep 12, 2012·The Journal of Infectious Diseases·Inoni BetuelaIvo Mueller
Dec 24, 2013·Lancet·Alejandro Llanos-CuentasLynda Kellam
Jan 28, 2014·PloS One·Katia BruxvoortDavid Schellenberg
Aug 29, 2014·Cadernos de saúde pública·Luciano Rodrigues SimõesCor Jesus Fernandes Fontes
Sep 13, 2014·Journal of Infection in Developing Countries·Gabriel de Deus VieiraCamila Maciel de Sousa
May 12, 2016·Malaria Journal·Sheila Vitor-SilvaMarcus Vinícius Guimarães Lacerda
May 19, 2016·Revista Da Sociedade Brasileira De Medicina Tropical·Eduardo Dias Almeida, José Luiz Fernandes Vieira
Feb 3, 2018·Malaria Journal·Larissa W BrasilGuilherme Suarez-Kurtz
Jul 24, 2018·The Lancet Infectious Diseases·Robert J CommonsRic N Price
Jan 24, 2019·Malaria Journal·André DaherDavid G Lalloo
Jan 31, 2019·The Journal of Infectious Diseases·Elizabeth A AshleyNicholas J White
Oct 10, 2019·Future Microbiology·Fernando ValMarcus Vg Lacerda